INSMED Inc
For the period ended Dec 31, 2025. Filed Feb 19, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 19, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 16. FORM 10-K SUMMARY
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on February 19, 2026.
| INSMED INCORPORATEDa Virginia corporation(Registrant) | |
| By: | /s/ WILLIAM H. LEWIS |
| William H. Lewis Chair and Chief Executive Officer(Principal Executive Officer) |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities indicated on February 19, 2026.
| Signature | Title |
|---|---|
| /s/ WILLIAM H. LEWIS | Chair and Chief Executive Officer(Principal Executive Officer) |
| William H. Lewis | |
| /s/ SARA BONSTEIN | Chief Financial Officer(Principal Financial and Accounting Officer) |
| Sara Bonstein | |
| /s/ DAVID R. BRENNAN | Lead Independent Director |
| David R. Brennan | |
| /s/ ELIZABETH MCKEE ANDERSON | Director |
| Elizabeth McKee Anderson | |
| /s/ CLARISSA DESJARDINS, PH.D. | Director |
| Clarissa Desjardins, Ph.D. | |
| /s/ LEO LEE | Director |
| Leo Lee | |
| /s/ DAVID W.J. MCGIRR | Director |
| David W.J. McGirr | |
| /s/ CAROL A. SCHAFER | Director |
| Carol A. Schafer | |
| /s/ MELVIN SHAROKY, M.D. | Director |
| Melvin Sharoky, M.D. | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.